Features
Winnipeg-born and raised Michael Lang is at the forefront of a technological innovation that can help to change the way neurosurgery is performed and how brain diseases such as Alzheimer’s Disease are treated
By BERNIE BELLAN We’ve often heard that one of the main reasons Manitoba lags behind other provinces when it comes to economic development is because there is both a lack of entrepreneurial capital in this province and innovative individuals who are willing to base their operations here.
Thus, it was refreshing to hear of one young man who not only grew up in Winnipeg, but who has also decided to stay here and work to help turn a company which he co-founded into a successful start-up.
That young man’s name is Michael Lang, 37. I first met Michael when he was in a bar mitzvah class at Temple Shalom with my daughter, Shira. Having grown up in River Heights, the son of Ida and Sherman Lang, Michael attended, in order, Ecole Robert H. Smith, River Heights Middle School, and Kelvin High School.
Michael notes that, as a young boy, he and several other students, including Ben Carr, would go to Hebrew teacher Ethel Amihude’s home for Hebrew lessons. As a side note I should mention that the same day I interviewed Michael for this story, I also received a phone call from Ben Carr, who is now the Member of Parliament for Winnipeg South Centre. When I mentioned to Ben that I had just got off the phone with his former classmate Michael Lang, Ben said to me that, during the rally held in support of Israel on October 10, at which Ben spoke, he was approached by a woman who said, “I’ll bet you don’t remember me. I taught you Hebrew in my home.” Of course, it was Ethel Amihude – and yes, Ben did recognize her immediately.
Returning to Michael Lang – upon graduating from Kelvin High School, Michael enrolled at the University of Winnipeg to study science, with a particular interest in Physics, which is something he’s always loved, he says. Michael went on to complete his Masters and Ph.D. in Physics at the University of Manitoba, he notes, although his he did much of his research at the University of Winnipeg – “a great experience,” he observes.
I asked him how the Physics Department at the University of Winnipeg would compare with other Physics departments in Canada and the US and, although Michael acknowledges that “it’s a small faculty” – maybe 10 professors in total, they definitely “punch above their weight.”
Now, in order to keep this article at a level that would be understandable to most readers (and to this writer as well), I wanted to avoid asking Michael to go into any great detail about what his area of specialty in Physics was, but – just to give you a taste of what it was that he concentrated upon in his studies, here’s a brief excerpt from his bio on the company website (known as tauMEDIS) that he’s helped to found: “Michael received his Ph.D. in Physics from the University of Manitoba with work on hyperpolarized 129Xe gas production for high-precision co-magnetometry.”
The key word in that sentence is “magnetometry,” because it helps to explain how Michael’s research in that field eventually led him into the field of magnetic resonance imaging – or, as the acronym of that term is much more familiar to most of us: “MRI.”
By now, getting an MRI performed for a host of medical issues is something a lot of us expect to have done – and not with undue delays – and when we must wait for an MRI to be performed, which was something greatly exacerbated as a result of Covid disruptions to our medical system, it can be excruciatingly trying.
In the spring of 2020 – shortly after the start of the pandemic, Michael was working as a lab technician at the University of Winnipeg, where he maintained that university’s small animal MRI facility. It was then that the Principal Investigator of the lab, Dr. Melanie Martin, introduced Michael to members of a group working on a novel intraoperative MRI system. Michael would soon after join the group as a post-doctoral fellow, helping to lay the groundwork for what became tauMEDIS.
What is tauMEDIS? According to information available on its website, “Originally formed in 2018, and officially founded in 2023 by a group of Canadian scientists and engineers who are passionate about medical imaging, the name TauMEDIS is an acronym for tau Medical Imaging Solutions…” (tau is a letter in the Greek alphabet that “has significance in both magnetic resonance imaging as well as a variety of neurodegenerative diseases.”)
Although there are a host of other companies active in producing MRI systems, tauMEDIS has developed a particular type of technology in a specialized area of magnetic resonance imaging known as iMRI: “Intraoperative magnetic resonance imaging” or “iMRI,” for short. iMRI is a “method to acquire updated images of the brain throughout a neurosurgical procedure. Neurosurgeons rely on iMRI technology to obtain accurate images of the brain that guide them in removing brain tumors and treating other conditions such as epilepsy.”
Where tauMEDIS is unique in this highly specialized field though, is in its having developed a method to mobilize a full-sized MRI machine that, not only does not require the patient to be moved from the operating table into another room to have an MRI performed, it optimizes the installation process, allowing for retrofitting in existing operating rooms. (There is another company that makes moving magnet iMRI machines, known as IMRIS, that also allows the patient to remain on the operating table during surgery without having to be moved, but incorporating those particular systems into hospitals usually involves making major changes to the infrastructure of existing operating rooms.) The tauMEDIS system, Michael explains, minimizes renovations, and drastically reduces installation time in existing operating facilities.
“We developed a method to mobilize the MRI on a floor-moving track-based vehicle,” he says. “Essentially it’s a high-precision tank-like device that brings the MRI system to the patient undergoing neurosurgery,” providing the surgical team with updated images of the brain throughout the procedure.
tauMEDIS was just recently incorporated in Manitoba (six months ago). In March of this year its prototype machine received approval from the Food and Drug Administration in the US.
Now, in addition to his role as the company’s Chief Technology Officer, Michael, along with the other principals in the company, have found themselves in the position of having to seek out investment funds for tauMEDIS to commercialize the iMRI system they have developed. The funding would support development of a Winnipeg facility that would begin producing actual systems for sale.
“We just recently had our first showing at the Congress of Neurological Surgeons,” Michael says, “and now we’re in the fund-raising phase.”
I asked him how much money they’re seeking, and he says, “$200,000 to start.” I said to him that doesn’t seem like a lot to ask for and that I wondered whether having this article appear in this paper might not be just what it would take to elicit a positive response from some would-be investors.
Further, Michael notes that the goal of tauMEDIS “is to set up a local facility, combining manufacturing and R&D of tauMEDIS products, all located right here in Manitoba. We hope to attract and develop talent, growing the Winnipeg medical device sector.” (I should also mention that years ago, when I was writing about the Crocus Investment Fund, I noted that one of the first investee companies for Crocus was that very same IMRIS, to which I previously referred. I asked Michael if he knew whatever became of IMRIS back then since, according to Michael, it has now become very successful. As I recall, the Crocus Fund lost its entire investment in IMRIS. According to Michael, the company is now based in Minnesota. What happened after the Crocus debacle I’m not sure – just another example of a company that had a great idea but, for whatever reason, couldn’t succeed in Manitoba – although it did take off when it relocated elsewhere.)
Not only is tauMEDIS seeking capital to begin producing its iMRI systems, it also has other technological innovations in the works – all in the area of medical imaging. As Michael Lang says, his “goal as Chief Technology Officer is to work with physicians around the world to make advances in medical imaging technology and develop novel solutions” that would dramatically improve patient health outcomes.
If you would like to find out more about tauMEDIS, email info@taumedis.com or go to its website: taumedis.ca.
Features
Football: Which team from Israel could we see in the European Cup next year?
With Europe’s club competitions heading into another summer of drama, Israeli football is on the table. The domestic season is done, trophies picked up and now a new batch of clubs can now try their luck against continental competition.
What are the prospects of these teams in Europe next year and who are they? It all starts with Hapoel Be’er Sheva’s title, Maccabi Tel Aviv’s cup win and the competition of the best Israel football teams against each other, as fans look to Champions League on Wincomparator to see what teams are in contention.
How Israel’s clubs qualify for Europe: The 2026-2027 spots
Qualification to join the European elite hinges on the 2025-26 Israeli Premier League table and the Israel State Cup. Israel will have one Champions League spot, one Europa League spot, and two Europa Conference League spots in 2026-27.
That means the league winner gets into the Champions League, the State Cup winner goes on to Europa League qualifying. The next eligible league’s finishers take the Conference League slots. It’s a good model as it provides a tangible reward for consistency at home, while at the same time demonstrating the importance of each playoff game. A top three finish can help a club’s summer, bring in better players and provide fans with a European tour before the next season’s start.
The Champion’s quest: Israel’s hope for the Champions League
Meet the 2025-26 Premier League winner: Hapoel Be’er Sheva
Hapoel Be’er Sheva have qualified for Israel’s Champions League after their Israeli Premier League title win with 79 points scored in 36 games. Ran Kozuch’s side closed the gap on the three-point lead but also showed significant strength in the attacking phase to secure a win in a crucial championship round with Beitar Jerusalem.
Their challenge also comes as their reward. Hapoel Be’er Sheva are only expected to begin in the second round of the Champions League, not the league round. To get to the main competition they need to pass through the first round of the other national champions in two-legged ties, and their seeding, fitness and sharpness in early-season competition could be a game breaker.
While the club has experience in Europe and a rabid Turner Stadium following, the path is tough. It takes one bad outing to wipe out a year’s worth of work. However, as long as the bedrock remains the same and they are able to put some depth into the team, the champions have the balance to fight.
Battling in the Conference League: Israel’s other European contenders
The State Cup winner and league runners-up
Maccabi Tel Aviv go to Europe after the Israel State Cup final 2-1 win against Hapoel Be’er Sheva at Teddy Stadium, Jerusalem. That win denied Be’er Sheva a home double, and also meant that Maccabi got into the Europa League qualifying, where they were put in the second qualifying round thanks to access-list rebalancing.
The Conference League qualifiers are Beitar Jerusalem who finished second in the league with 76 points, and Hapoel Tel Aviv who finished fourth with 60 points. The importance of Maccabi Tel Aviv’s cup victory lies in the fact that it unlocked the rest of the way in the league. Beitar’s season was particularly impressive as they scored 78 goals and lost just four matches. On the other hand, Hapoel Tel Aviv managed to remain above Maccabi Haifa in the final table standing, earning them a well-deserved European berth.
The Europa Conference League is no consolation prize for these clubs. It’s a realistic platform. Although there are still a few hurdles to navigate, Israeli sides consider this competition to be the most realistic one for European football in the autumn.
A look at past successes and future hopes
This group has reason for belief, based on recent history. Israeli teams can make significant nights in Europe, and Maccabi Haifa did just that, when they made it into the Champions League group stage in 2022-23, and then impressively took out Juventus 2-0 in Haifa.
There is significant monetary and sporting worth in qualification. A UEFA cup can make a difference to a club, as can better attendance, TV coverage and recruitment opportunities. The early storylines will be the draw for Hapoel Be’er Sheva in the Champions League, as well as Maccabi Tel Aviv in the Europa league and the two Conference League routes — Beitar Jerusalem and Hapoel Tel Aviv. They all have tricky paths to follow, but all four provide Israeli football with a realistic European presence next summer.
Features
At one time one entire block of McAdam Ave. was almost totally Jewish
This story originally appeared in a November 2014 issue of The Jewish Post & News:
1994 McAdam Ave. reunion (names inside story)By GERRY POSNER (This story first appeared in November 2014.)
Once upon a time when life was simpler and gentler, there was a street in the north end of Winnipeg which was like all other streets in the city except in one significant way. Everyone, but for one family, living on McAdam east of Main Street was Jewish.
Features
Cheap Weed In Canada: A Smart Shopper’s Guide
Since legalisation, cannabis has settled into Canadian life as an ordinary, regulated purchase. And like groceries or gas, the price can vary a surprising amount from one shop to the next once you start comparing.
For a lot of buyers, that has turned the focus to value. Affordable options like cheap weed prove a lower price and a tested, quality product can go together. This guide explains how to shop smart in Canada without cutting corners.
Why Has Affordable Cannabis Become So Popular?
Because the novelty has worn off, and buyers now shop like they do for anything else. In the early days, people paid whatever the new legal stores asked. That has changed.
A few things drove that shift:
- A maturing market, with more retailers competing on price.
- Online sellers, whose lower overhead keeps costs down.
- Savvier buyers, who now compare rather than grab the first option.
- A wider range of formats and budget-friendly bulk sizes.
The result is a real focus on getting value for money. Crowdsourced figures put the early average near $6.85 a gram, and cannabis price data from Statistics Canada shows how legal and illegal prices have differed since 2018.
That gap is exactly why shopping around pays off. A careful buyer can pay noticeably less than a careless one for a comparable product. The sticker price is only where the comparison starts.
How Do Canadians Shop for Cheaper Weed?
With the same care they bring to any regular expense. A handful of habits make the biggest difference. These are the ones worth adopting:
- Compare the per-gram price. It is the only fair way to weigh two options.
- Buy larger formats. Bigger quantities almost always lower the unit cost.
- Skip premium markups. Plain flower beats pricey pre-rolls for value.
- Watch for sales. Online retailers run them often, especially on holidays.
- Match potency to the plan. A stronger product means you use less each time.
None of these involve settling for a worse product. They simply put your money to better use, the same way you would stretch your money on any other purchase. The cheapest sticker is rarely the best value, and the priciest is seldom worth it.
The same logic applies whether you shop in person or online in Canada. Read the label, weigh the cost per gram, and let the numbers guide you rather than the branding.
Is There a Catch With Low-Priced Cannabis?
Not in the legal market, which is the part newcomers miss. In Canada, every legal product is tested and labelled to the same standard, whatever it costs.
That means a budget option from a licensed seller has cleared the same checks as a premium one. It is screened for contaminants, and its potency is verified. Price reflects branding, packaging, and store margins far more than basic safety.
The genuine differences are in the finer points. Premium flower might offer a better aroma or a richer flavour, and some formats simply cost more to make. For everyday use, though, a well-priced choice usually performs just fine.
The real catch is buying outside the legal system. Health Canada’s overview of the Cannabis Act is a sensible read on what legal really means. Buying legal protects you, not buying expensive.
What Makes a Cheap Purchase a Smart One?
A couple of quick checks, mostly. A real bargain holds up to a second look, while a false one does not. The table below shows what to weigh.
| Check | Why It Matters |
| Is the seller licensed? | Only legal retailers guarantee tested product |
| What is the per-gram cost? | The headline price can hide a weak deal |
| Is potency on the label? | Higher strength can stretch your money |
| Are there bulk or sale deals? | These usually beat single-unit pricing |
| What does delivery cost? | Shipping can erase an online saving |
Any shaky answer there is a reason to pause. A licensed seller with clear pricing and labelling is the safe choice, while a suspiciously cheap unlicensed source is not. The legal age applies regardless, at 18 or 19 depending on the province.
Treat cannabis like any other considered purchase. Compare, check the details, and let value rather than habit lead the decision. That is how modest savings add up across a whole year.
Before You Buy
- Cannabis prices vary widely by retailer, format, and store overhead.
- Comparing the per-gram cost is the fairest way to judge value.
- All legal Canadian cannabis is tested, so cheaper is not unsafe.
- Bulk buys, sales, and plain formats keep spending down.
- Always buy from a licensed source, and factor in delivery fees.
Photo by Jakub Zerdzicki on Pexels
Alt text: A shopper comparing prices online at home
Smart Savings, No Compromise
Buying affordable cannabis in Canada is not about chasing the lowest number you can find. It is about understanding what shapes the price and shopping with a little intention. Stick to licensed, tested products, compare the real cost per gram, and lean on bulk deals and online pricing. Do that, and an affordable choice stays a smart one, purchase after purchase.
Frequently Asked Questions
Is Cheap Weed Safe to Buy In Canada?
Yes, provided it comes from a licensed retailer. All legal cannabis in Canada is tested for contaminants and labelled for potency, regardless of price. A lower cost usually reflects branding and overhead rather than weaker safety, so a budget option from a legal seller is still a safe one.
How Do I Find the Best Cannabis Deals?
Compare the per-gram price, buy larger formats, and watch for sales from online retailers. Checking potency against price helps too, since a stronger product can mean you use less. The key is shopping deliberately instead of defaulting to the same brand or store each time.
Why Is Cannabis Cheaper Online?
Online sellers usually carry lower overhead than physical stores, and they run sales and bulk deals more often. That lets them price competitively while still selling tested, legal product. Just remember to factor in shipping, which can offset the saving on a small order.
Does Paying More Mean Better Cannabis?
Not necessarily. Price reflects branding, format, and store margins as much as quality, and all legal product meets the same testing standards. Premium options may offer a better aroma or appearance, but a well-priced choice often works just as well day to day.
